TF and myeloid leukemia: With the possibility that metastatic tumor cells may upregulate TF up to ~1,000-fold compared to non-metastatic cells (235), TF can be considered as a potent pro-metastatic molecule present on solid and myeloid leukemia-derived ApoV (47, 48).